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• Small scale grow up
• Large scale grow up
• Induce 
• Grow for 48 hours
• Harvest 
• Production of roughly 1mg/ml of purified protein
• Goal: Produce 10-40 mg/ml of protein for co-crystallization 
with inhibitors 
• Ongoing Work: Characterize stability of the following 
mutants V80S, G156A, L240S, A419S
Aromatase (CYP19) is an enzyme that converts androgens into estrogens.    
It is a drug target to treat hormone-dependent breast cancer, yet current 
therapeutics often result in patient health deterioration due to unwanted 
side effects.  We want to recombinantly express high yields of stable 
aromatase to co-crystallize with our new, potent inhibitors.  These crystals 
will be used to produce a 3-D structure to visualize the protein-inhibitor 
complex.  We hope that the structure will help us understand the 
interactions that are essential for drug potency.  We currently produce 1 
mg/mL of protein. We hope to increase the stability with mutants A419S, 
G156A, L240S, and V80S.  Stable aromatase increases the likelihood of 
producing protein crystals.  With the 3-D structure obtained from the 
protein crystals, we can design novel inhibitors as potential candidates to 












































• DPN1, and ligation reaction
• Transformation
• Mini-prep and sequencing
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V80SF -
CTACAACCGTTCTTACGGCGAATTC
V80SR – TAGTTGCACGCAGAACCA
G156AF –
GTCTGGTCCGGCGCTGGTTCGTA
G156AR - AGCGCTTTCATAAAGAACG
L240SF –
AATTTCCTGGTCTTACAAAAAGTACGAAAAGTC
L240SR– TTGAAGAAAATGTCCGGC
A419SF –
CGAGAATTTTTCTAAGAATGTTCCGTACC
A419SR - AGGGTGAATTCGTTCGGT
